Artivion | CRY - 销售成本

金融业

USD

USD 883.16M

现金及等价物

USD 55.76M

USD 42.85M

USD 357.52M

USD 92.7M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 450.47M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 215.35M

USD 873.6M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 98M

贸易债权人

USD 18.34M

应收帐款人

USD 103.68M

	销售成本	更改		日
Abbott	USD 5.3B		380M	2026-03
Accuray	USD 116.17M		14.63M	2024-12
AngioDynamics	USD 37.29M		786K	2025-09
Artivion	USD 42.85M		3.86M	2025-12
AtriCure	USD 31.94M		3.22M	2026-03
Baxter International	USD 1.81B		587M	2026-03
Becton, Dickinson and Co.	USD 2.56B		281M	2026-03
Boston Scientific	USD 1.83B		8M	2026-03
Edwards Lifesciences	USD 362.6M		19.6M	2026-03
Inogen	USD 39.59M		1.27M	2024-09
Integra LifeSciences	USD 178.71M		14.73M	2026-03
J&J	USD 8.07B		103M	2026-03
Mesa Laboratories	USD 21.92M		1.78M	2024-09
Orthofix International	USD 66.63M		6.4M	2025-12
Pfizer	USD 4.59B		1.7B	2026-03
ResMed	USD 551.67M		4.17M	2026-03
Stryker	USD 2.36B		325M	2026-03
Tandem Diabetes Care	USD 122.92M		7.96M	2025-12
Teleflex	USD 240.84M		20.7M	2026-03
Terumo	JPY 151.3B		7.86B	2026-03
Trinity Biotech	USD 7.84M		3.14M	2025-09